Biological Medicine

Biological Medicine

       In 2018, Zein Biotechnology (formerly “Zein Pharmaceutical”) started to aim at the field of biologics. We are committed to arranging antibody, vaccine and cell therapy product pipelines and supporting projects through the introduction, investment, R&D and production cooperation, to build a biopharmaceutical industry covering the whole industrial chain of product development, clinical cooperation, declaration and marketing, commercialized production and supporting management.

       We collaborate with well-known enterprises in the field of biologics at home and abroad, enhance the strength of technical teams, build international standard systems and set up a comprehensive teaching and research platform and industrialization platform integrating research, education, training and practical operation to strengthen project incubation capacity and industrialization capability and contribute to the transformation and upgrading of the city’s pharmaceutical industry.